Audit 7647

FY End
2023-03-31
Total Expended
$793,790
Findings
0
Programs
2
Year: 2023 Accepted: 2023-12-20
Auditor: Marcum LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.855 Allergy, Immunology and Transplantation Research $500,330 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $293,460 Yes 0

Contacts

Name Title Type
XLCWGCZH8NJ4 Chris Bluhm Auditee
3012721184 Doug Boedeker Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: Auditee used NICRA The accompanying schedule of expenditures of federal awards of the American Gastroenterological Association, Inc. and Affiliates is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in the preparation of, the basic financial statements.